BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li B, Gao MH, Chu XM, Xu YJ, Yang F. Identification of a novel short peptide seal specific to CD59 and its effect on HeLa cell growth and apoptosis. Cell Oncol (Dordr) 2012;35:355-65. [PMID: 22945508 DOI: 10.1007/s13402-012-0096-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Mehta P, Kaushik R, Singh KP, Sharma A, Singh MK, Chauhan MS, Palta P, Singla SK, Manik RS. Establishment, Growth, Proliferation, and Gene Expression of Buffalo ( Bubalus bubalis ) Transgenic Fetal Fibroblasts Containing Human Insulin Gene, and Production of Embryos by Handmade Cloning Using These Cells. Cellular Reprogramming 2018;20:135-43. [DOI: 10.1089/cell.2017.0013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
2 Bicak B, Kecel Gunduz S, Budama Kilinc Y, Imhof P, Gok B, Akman G, Ozel AE. Structural, spectroscopic, in silico, in vitro and DNA binding evaluations of tyrosyl-lysyl-threonine. J Biomol Struct Dyn 2021;:1-17. [PMID: 34463215 DOI: 10.1080/07391102.2021.1968499] [Reference Citation Analysis]
3 Sugumaran A, Mathialagan V. Colloidal Nanocarriers as Versatile Targeted Delivery Systems for Cervical Cancer. Curr Pharm Des 2020;26:5174-87. [PMID: 32586249 DOI: 10.2174/1381612826666200625110950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Jiang L, Wang Y, Zhu F, Liu G, Liu H, Ji H, Zheng S, Li B. Molecular Mechanism of Anti-Cancer Activity of the Nano-Drug C-PC/CMC-CD59sp NPs in Cervical Cancer. J Cancer 2019;10:92-104. [PMID: 30662529 DOI: 10.7150/jca.27462] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Wang Y, Jiang L, Yin Q, Liu H, Liu G, Zhu G, Li B. The Targeted Antitumor Effects of C- PC/CMC-CD59sp Nanoparticles on HeLa Cells in Vitro and in Vivo. J Cancer 2017;8:3001-13. [PMID: 28928892 DOI: 10.7150/jca.21059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li G, Yin Q, Ji H, Wang Y, Liu H, Jiang L, Zhu F, Li B. A study on screening and antitumor effect of CD55-specific ligand peptide in cervical cancer cells. Drug Des Devel Ther 2018;12:3899-912. [PMID: 30519000 DOI: 10.2147/DDDT.S182337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yang P, Li B, Yin QF, Wang YJ. Carboxymethyl chitosan nanoparticles coupled with CD59-specific ligand peptide for targeted delivery of C-phycocyanin to HeLa cells. Tumour Biol 2017;39:1010428317692267. [PMID: 28347253 DOI: 10.1177/1010428317692267] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]